Michael Böhm Selected Research

Michael Böhm Research Topics

Disease

223	Heart Failure 08/2022 - 02/2002
146	Hypertension (High Blood Pressure) 06/2022 - 01/2002
43	Atrial Fibrillation 06/2022 - 06/2003
42	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2002
39	Myocardial Infarction 04/2022 - 06/2002
39	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 03/2002
33	Fibrosis (Cirrhosis) 02/2022 - 02/2002
31	Systolic Heart Failure 01/2021 - 11/2007
30	Atherosclerosis 01/2021 - 12/2002
22	Inflammation (Inflammations) 02/2022 - 07/2002
22	Stroke (Strokes) 01/2022 - 06/2002
22	Cardiogenic Shock 01/2021 - 08/2007
18	Left Ventricular Dysfunction 04/2022 - 02/2002
17	Cardiomyopathies (Cardiomyopathy) 01/2022 - 10/2002
16	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2008
15	Hypertrophy 01/2022 - 09/2002
15	Shock 01/2021 - 03/2004
12	Chronic Renal Insufficiency 02/2022 - 08/2013
11	Cardiomegaly (Heart Hypertrophy) 01/2013 - 02/2002
10	Diabetes Mellitus 01/2018 - 10/2008
9	Vascular Diseases (Vascular Disease) 01/2021 - 08/2006
9	Coronary Disease (Coronary Heart Disease) 10/2017 - 03/2002
9	Acute Coronary Syndrome 03/2017 - 02/2002
8	Heart Diseases (Heart Disease) 06/2022 - 09/2002
8	Hypotension (Low Blood Pressure) 01/2022 - 07/2010
8	Hemorrhage 01/2021 - 01/2008
8	Infarction (Infarctions) 01/2021 - 02/2002
8	Thrombosis (Thrombus) 10/2020 - 02/2003
8	Erectile Dysfunction 01/2016 - 05/2003
7	Body Weight (Weight, Body) 01/2019 - 09/2002
7	Myocarditis (Carditis) 01/2019 - 01/2003
6	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2009
6	Dyslipidemias (Dyslipidemia) 01/2022 - 08/2009
6	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2008
6	Ventricular Remodeling 01/2021 - 12/2004
6	Atherosclerotic Plaque (Atheroma) 01/2020 - 05/2008
6	Bradycardia 12/2016 - 09/2009
6	Essential Hypertension 01/2016 - 01/2004
6	Peripheral Arterial Disease 12/2015 - 03/2007
5	COVID-19 05/2022 - 12/2020
5	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021 - 02/2002

Drug/Important Bio-Agent (IBA)

45	IvabradineIBA 01/2019 - 01/2007
35	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 02/2002
33	Antihypertensive Agents (Antihypertensives)IBA 06/2022 - 09/2010
23	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 01/2002
20	DiureticsIBA 06/2022 - 06/2003
20	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2004
20	Pharmaceutical PreparationsIBA 01/2022 - 06/2004
20	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 10/2007
18	Ramipril (Altace)FDA LinkGeneric 01/2021 - 02/2002
16	salicylhydroxamic acid (SHAM)IBA 06/2022 - 03/2002
16	Telmisartan (Micardis)FDA Link 01/2021 - 09/2006
16	CholesterolIBA 12/2019 - 06/2002
14	empagliflozinIBA 01/2022 - 01/2019
12	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2002
12	Rosuvastatin Calcium (Crestor)FDA Link 06/2014 - 06/2002
11	dapagliflozinIBA 01/2022 - 11/2019
11	LipidsIBA 01/2021 - 03/2002
10	CreatinineIBA 01/2022 - 11/2005
10	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 06/2009
10	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2020 - 04/2007
10	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 05/2006
10	CollagenIBA 01/2020 - 03/2007
10	Nebivolol FDA Link 01/2015 - 11/2002
9	SodiumIBA 04/2022 - 12/2012
9	Messenger RNA (mRNA)IBA 01/2020 - 05/2002
9	Indicators and Reagents (Reagents)IBA 10/2017 - 04/2009
9	Angiotensin IIIBA 06/2010 - 03/2002
8	Angiotensin Receptor AntagonistsIBA 01/2022 - 01/2002
8	Sodium-Glucose Transport ProteinsIBA 01/2022 - 11/2019
8	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 04/2002
8	Natriuretic PeptidesIBA 03/2021 - 01/2015
8	ReninIBA 01/2021 - 02/2002
8	AldosteroneIBA 10/2016 - 03/2002
7	Eplerenone (Inspra)FDA LinkGeneric 04/2022 - 07/2010
7	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 04/2010
7	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 11/2019
7	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 09/2010
7	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 01/2015
7	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 10/2003
7	aliskiren FDA Link 01/2018 - 11/2010
7	Adrenergic Agents (Adrenergic Drugs)IBA 05/2013 - 03/2002
7	erucylphosphocholineIBA 05/2011 - 01/2004
6	Apolipoproteins E (ApoE)IBA 01/2016 - 10/2006
6	Interleukin-6 (Interleukin 6)IBA 07/2015 - 02/2002
6	C-Reactive ProteinIBA 08/2014 - 02/2002
6	Atrial Natriuretic Factor (ANF)IBA 03/2013 - 03/2002
5	omega-Chloroacetophenone (Mace)IBA 04/2022 - 10/2008

Therapy/Procedure

137	Therapeutics 08/2022 - 01/2002
97	Denervation 06/2022 - 12/2010
45	Catheters 06/2022 - 05/2009
40	Sympathectomy (Sympathectomies) 01/2021 - 12/2010
11	Stents 07/2020 - 04/2003
10	Drug Therapy (Chemotherapy) 02/2022 - 08/2007
10	Patient Readmission 01/2022 - 06/2009
9	Heart Transplantation (Grafting, Heart) 11/2021 - 08/2008
9	Percutaneous Coronary Intervention 01/2021 - 01/2008
6	Secondary Prevention 02/2019 - 04/2003
6	Aftercare (After-Treatment) 12/2016 - 09/2006
5	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 10/2002